171 related articles for article (PubMed ID: 12909310)
21. Homocysteine and cardiovascular disease in renal disease.
Austen SK; Coombes JS; Fassett RG
Nephrology (Carlton); 2003 Dec; 8(6):285-95. PubMed ID: 15012699
[TBL] [Abstract][Full Text] [Related]
22. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation.
Heil SG; De Vriese AS; Kluijtmans LA; Mortier S; Den Heijer M; Blom HJ
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):911-6. PubMed ID: 15704255
[TBL] [Abstract][Full Text] [Related]
23. Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit.
Perna AF; Ingrosso D; Violetti E; Luciano MG; Sepe I; Lanza D; Capasso R; Ascione E; Raiola I; Lombardi C; Stenvinkel P; Massy Z; De Santo NG
Semin Dial; 2009; 22(4):351-6. PubMed ID: 19708980
[TBL] [Abstract][Full Text] [Related]
24. Adenosine inhibits human astrocyte proliferation independently of adenosine receptor activation.
Marcelino H; Nogueira VC; Santos CRA; Quelhas P; Carvalho TMA; Fonseca-Gomes J; Tomás J; Diógenes MJ; Sebastião AM; Cascalheira JF
J Neurochem; 2020 May; 153(4):455-467. PubMed ID: 31811731
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine Modification in Protein Structure/Function and Human Disease.
Jakubowski H
Physiol Rev; 2019 Jan; 99(1):555-604. PubMed ID: 30427275
[TBL] [Abstract][Full Text] [Related]
26. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function.
Chen YF; Li PL; Zou AP
Circulation; 2002 Sep; 106(10):1275-81. PubMed ID: 12208805
[TBL] [Abstract][Full Text] [Related]
27. ADMA and hyperhomocysteinemia.
Dayal S; Lentz SR
Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular pathogenesis in hyperhomocysteinemia.
Huang T; Yuan G; Zhang Z; Zou Z; Li D
Asia Pac J Clin Nutr; 2008; 17(1):8-16. PubMed ID: 18364320
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine, intracellular signaling and thrombotic disorders.
Dionisio N; Jardín I; Salido GM; Rosado JA
Curr Med Chem; 2010; 17(27):3109-19. PubMed ID: 20629621
[TBL] [Abstract][Full Text] [Related]
30. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
31. Roles of homocysteine in cell metabolism: old and new functions.
Medina M; Urdiales JL; Amores-Sánchez MI
Eur J Biochem; 2001 Jul; 268(14):3871-82. PubMed ID: 11453979
[TBL] [Abstract][Full Text] [Related]
32. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
33. Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
Socha MW; Polakowska MJ; Socha-Urbanek K; Fiedor P
Ann Transplant; 1999; 4(1):11-9. PubMed ID: 10850596
[TBL] [Abstract][Full Text] [Related]
34. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Capelli I; Cianciolo G; Gasperoni L; Zappulo F; Tondolo F; Cappuccilli M; La Manna G
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781775
[TBL] [Abstract][Full Text] [Related]
35. Remote ischemic conditioning as a cytoprotective strategy in vasculopathies during hyperhomocysteinemia: An emerging research perspective.
Majumder A; Singh M; George AK; Homme RP; Laha A; Tyagi SC
J Cell Biochem; 2019 Jan; 120(1):77-92. PubMed ID: 30272816
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia.
Tyagi N; Moshal KS; Ovechkin AV; Rodriguez W; Steed M; Henderson B; Roberts AM; Joshua IG; Tyagi SC
J Cell Biochem; 2005 Nov; 96(4):665-71. PubMed ID: 16149054
[TBL] [Abstract][Full Text] [Related]
37. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart.
Schrader J; Schütz W; Bardenheuer H
Biochem J; 1981 Apr; 196(1):65-70. PubMed ID: 7306081
[TBL] [Abstract][Full Text] [Related]
38. Homocysteine: an emerging age-related cardiovascular risk factor.
Moustapha A; Robinson K
Geriatrics; 1999 Apr; 54(4):41, 44-6, 49-51. PubMed ID: 10212627
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine: an emergent cardiovascular risk factor?
Medina MA; Amores-Sánchez MI
Eur J Clin Invest; 2000 Sep; 30(9):754-62. PubMed ID: 10998074
[TBL] [Abstract][Full Text] [Related]
40. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
Papatheodorou L; Weiss N
Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
